Showing results (21-30 of 44) with videos related to
Sort By:
Pageof 5
Cell Death & Disease|January 18, 2014
Prostasin may contribute to chemoresistance, repress cancer cells in ovarian cancer, and is involved in the signaling pathways of CASP/PAK2-p34/actinB-x Yan, J-x Ma, J Zhang, et al.Medical Oncology (Northwood, London, England)|June 1, 1996
Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) results of protocol E1293A I Einzig, D Neuberg, S C Remick, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
Continuous infusion bleomycin in AIDS-related Kaposi's sarcomaS C Remick, M Reddy, D Herman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
Multi-institutional phase I/II trial of paclitaxel, cisplatin, and etoposide with concurrent radiation for limited-stage small-cell lung carcinomaN Levitan, A Dowlati, D Shina, et al.Oncogene|November 5, 2013
PSP94 contributes to chemoresistance and its peptide derivative PCK3145 represses tumor growth in ovarian cancerB-X Yan, J-X Ma, J Zhang, et al.American Journal of Hematology|April 6, 2001
Oral combination chemotherapy in conjunction with filgrastim (G-CSF) in the treatment of AIDS-related non-Hodgkin's lymphoma: evaluation of the role of G-CSF; quality-of-life analysis and long-term follow-upS C Remick, N Sedransk, R F Haase, et al.East African Medical Journal|April 20, 2006
Strategies to overcome myelotoxic therapy for the treatment of Burkitt's and AIDS-related non-Hodgkin's lymphomaR Rochford, G Feuer, J Orem, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer: an Eastern Cooperative Oncology Group pilot studyD J Adelstein, L A Kalish, G L Adams, et al.Cell Death & Disease|September 5, 2014
PSP94, an upstream signaling mediator of prostasin found highly elevated in ovarian cancerJ-x Ma, B-x Yan, J Zhang, et al.American Journal of Clinical Oncology|April 1, 1996
Concurrent 72-hour continuous infusion of etoposide and cisplatin in metastatic breast cancerS C Remick, M Chmura, C Bromberg, et al.Pageof 5